Genzyme Corp. (Nasdaq:GENZ) has marked the grand opening of its new Science Center in Framingham, Mass. The facility serves as a central site for early stage research, where scientists are utilizing the most advanced technologies available to discover novel new treatments for devastating diseases such as Parkinson's, cancer, and heart disease.
Discuss Add this link to...Bury Add to:
| Bookmarks
Comments